Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q34421883)
Watch
English
Diagnosis and treatment of multiple sclerosis
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed ID
16513709
retrieved
2 August 2017
review article
1 reference
stated in
Europe PubMed Central
title
Diagnosis and treatment of multiple sclerosis.
(English)
1 reference
stated in
Europe PubMed Central
PubMed ID
16513709
retrieved
2 August 2017
main subject
multiple sclerosis
0 references
author name string
T J Murray
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
16513709
retrieved
2 August 2017
language of work or name
English
0 references
publication date
1 March 2006
1 reference
stated in
Europe PubMed Central
PubMed ID
16513709
retrieved
2 August 2017
number of pages
3
1 reference
based on heuristic
inferred from page(s)
published in
The BMJ
1 reference
stated in
Europe PubMed Central
PubMed ID
16513709
retrieved
2 August 2017
volume
332
1 reference
stated in
Europe PubMed Central
PubMed ID
16513709
retrieved
2 August 2017
issue
7540
1 reference
stated in
Europe PubMed Central
PubMed ID
16513709
retrieved
2 August 2017
page(s)
525-527
1 reference
stated in
Europe PubMed Central
PubMed ID
16513709
retrieved
2 August 2017
cites work
Clinical implications of benign multiple sclerosis: a 20-year population-based follow-up study.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1388131
retrieved
6 July 2018
The neuropsychiatry of multiple sclerosis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1388131
retrieved
6 July 2018
The use of mitoxantrone (Novantrone) for the treatment of multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1388131
retrieved
6 July 2018
The utility of MRI in suspected MS: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1388131
retrieved
6 July 2018
Disease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1388131
retrieved
6 July 2018
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1388131
retrieved
6 July 2018
Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1388131
retrieved
6 July 2018
The bioavailability of IV methylprednisolone and oral prednisone in multiple sclerosis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1388131
retrieved
27 October 2018
Diagnosis of multiple sclerosis: comparison of the Poser criteria and the new McDonald criteria
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1388131
retrieved
27 October 2018
Mitoxantrone in progressive multiple sclerosis: a placebo-controlled, double-blind, randomised, multicentre trial
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1388131
retrieved
27 October 2018
Neutralizing anti-IFN-beta antibodies: how much more evidence do we need to use them in practice?
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/16513709
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Neutralizing antibodies and efficacy of interferon beta-1a: a 4-year controlled study
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/16513709
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Complementary and alternative medicine for MS
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/16513709
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Identifiers
DOI
10.1136/BMJ.332.7540.525
1 reference
stated in
Europe PubMed Central
PubMed ID
16513709
retrieved
2 August 2017
PMCID
1388131
1 reference
stated in
Europe PubMed Central
PubMed ID
16513709
retrieved
2 August 2017
PubMed ID
16513709
1 reference
stated in
Europe PubMed Central
PubMed ID
16513709
retrieved
2 August 2017
ResearchGate publication ID
7263676
0 references
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
